Literature DB >> 1675890

Auditory event-related potentials and electrodermal activity in medicated and unmedicated schizophrenics.

W T Roth1, J Goodale, A Pfefferbaum.   

Abstract

Event-related potentials (ERPs) and electrodermal activity were studied in 14 medicated schizophrenics, 17 unmedicated schizophrenics, and 23 age- and education-matched controls. Subjects were run in three auditory stimulus paradigms differing from the usual ERP paradigms in having interstimulus intervals greater than 12 sec to permit measurement of the longer latency skin conductance response (SCR). In every paradigm medicated but not unmedicated schizophrenics had smaller N120 amplitudes and fewer SCRs than controls. In addition, medicated schizophrenics showed reduced P200 amplitude and latency, longer P320 latency, and reduced skin conductance levels in certain paradigms. These effects cannot easily be attributed to different mental states of medicated and unmedicated patients, since their Brief Psychiatric Rating Scale scores were almost the same. It is more probable that antipsychotic and antiparkinsonian drugs reduced electrodermal activity through anticholinergic mechanisms and that the antipsychotic drugs attenuated N120 through other biological mechanisms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675890     DOI: 10.1016/0006-3223(91)90094-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  9 in total

Review 1.  Anticipating the future: automatic prediction failures in schizophrenia.

Authors:  Judith M Ford; Daniel H Mathalon
Journal:  Int J Psychophysiol       Date:  2011-09-28       Impact factor: 2.997

2.  Neuromagnetic evidence of broader auditory cortical tuning in schizophrenia.

Authors:  Donald C Rojas; Erin Slason; Peter D Teale; Martin L Reite
Journal:  Schizophr Res       Date:  2007-09-12       Impact factor: 4.939

Review 3.  Electroencephalography and Event-Related Potential Biomarkers in Individuals at Clinical High Risk for Psychosis.

Authors:  Holly K Hamilton; Alison K Boos; Daniel H Mathalon
Journal:  Biol Psychiatry       Date:  2020-04-14       Impact factor: 13.382

4.  Auditory evoked potentials in schizophrenic patients before and during neuroleptic treatment. Relationship to psychopathological state.

Authors:  G Adler; W F Gattaz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

5.  A putative electrophysiological biomarker of auditory sensory memory encoding is sensitive to pharmacological alterations of excitatory/inhibitory balance in male macaque monkeys.

Authors:  William B Holliday; Kate Gurnsey; Robert A Sweet; Tobias Teichert
Journal:  J Psychiatry Neurosci       Date:  2018-05       Impact factor: 6.186

6.  When it's time for a change: failures to track context in schizophrenia.

Authors:  Judith M Ford; Brian J Roach; Ryan M Miller; Connie C Duncan; Ralph E Hoffman; Daniel H Mathalon
Journal:  Int J Psychophysiol       Date:  2010-05-24       Impact factor: 2.997

7.  Loudness- and time-dependence of auditory evoked potentials is blunted by the NMDA channel blocker MK-801.

Authors:  Tobias Teichert
Journal:  Psychiatry Res       Date:  2017-06-15       Impact factor: 3.222

8.  Reductions in the N1 and P2 auditory event-related potentials in first-hospitalized and chronic schizophrenia.

Authors:  Dean F Salisbury; K C Collins; Robert W McCarley
Journal:  Schizophr Bull       Date:  2009-03-12       Impact factor: 9.306

9.  Using concurrent EEG and fMRI to probe the state of the brain in schizophrenia.

Authors:  Judith M Ford; Brian J Roach; Vanessa A Palzes; Daniel H Mathalon
Journal:  Neuroimage Clin       Date:  2016-08-10       Impact factor: 4.881

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.